The Allen Institute announced on September 28, 2026 that it is beginning a $95 million research initiative in Seattle to develop new proteins for cancer and disease treatment using artificial intelligence.
The effort will focus on creating novel protein therapeutics for cancer and other illnesses, reflecting a growing trend of employing AI to speed up biological design in health research.